This handout is for migraine. Your care team identified this based on: recurrent unilateral throbbing headache 4–72h (aan 2024).
Other reasons your team may use this plan: visual / sensory / language aura preceding headache (aan 2024); photophobia, phonophobia, nausea/vomiting (aan 2024); ≥4 headache days/month interfering with function (aan 2024).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| ibuprofen | 400–800 mg PO at onset | PO | PRN; max 3 d/week to avoid MOH | AHS 2025 — high-dose NSAID first-line for mild-moderate; cap days/month to prevent MOH |
| naproxen | 500–550 mg PO at onset | PO | PRN | Longer half-life; useful for menstrual migraine (AAN 2024) |
| acetaminophen | 1000 mg PO at onset | PO | PRN | Pregnancy-safe option (AAN 2024) |
Plan: Acute attack treatment ladder (AAN 2024)
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Reassess at 3 mo; switch CGRP class if no ≥50% response; lifestyle (sleep/hydration/exercise/CBT for headache); comorbidity treatment (depression/anxiety/obesity) (AAN 2024)
Guideline: ICHD-3 (Olesen Cephalalgia 2018) + AHS 2024 Acute Treatment Consensus + AHS 2021 Preventive Consensus + AHS 2024 Position Statement (CGRP first-line preventive) + PREEMPT (onabotulinumtoxinA in chronic migraine) + ACP 2025 Prevention Guideline + AHS 2025 ED Acute Treatment